Management of yolk sac tumors in children

J. A. Connolly, John Phillip Gearhart

Research output: Contribution to journalArticle

Abstract

The current trend toward minimizing treatment morbidity in children with yolk sac carcinomas is laudable. As most children will present with stage I disease and be cured by radical orchiectomy alone, careful surveillance is adequate with the knowledge that effective chemotherapy is available should tumor recur. All new yolk sac carcinomas in children should be reported to the Prepubertal Testicular Tumor Registry and should ideally be treated at institutions that have experience with surveillance protocols and pediatric oncology. In this way, prospective studies on treatment options can be initiated, and management controversies may ultimately be ironed out. In particular, more information is needed on patients more than 2 years old, as the literature to date is contradictory regarding the prognosis for these patients and the need for adjuvant therapy when the older child presents with stage I disease.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalUrologic Clinics of North America
Volume20
Issue number1
StatePublished - 1993

Fingerprint

Endodermal Sinus Tumor
Yolk Sac
Carcinoma
Orchiectomy
Testicular Neoplasms
Registries
Therapeutics
Prospective Studies
Pediatrics
Morbidity
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Management of yolk sac tumors in children. / Connolly, J. A.; Gearhart, John Phillip.

In: Urologic Clinics of North America, Vol. 20, No. 1, 1993, p. 7-14.

Research output: Contribution to journalArticle

@article{f66c3e19f3fd4e838ee8f7ab7731dfb0,
title = "Management of yolk sac tumors in children",
abstract = "The current trend toward minimizing treatment morbidity in children with yolk sac carcinomas is laudable. As most children will present with stage I disease and be cured by radical orchiectomy alone, careful surveillance is adequate with the knowledge that effective chemotherapy is available should tumor recur. All new yolk sac carcinomas in children should be reported to the Prepubertal Testicular Tumor Registry and should ideally be treated at institutions that have experience with surveillance protocols and pediatric oncology. In this way, prospective studies on treatment options can be initiated, and management controversies may ultimately be ironed out. In particular, more information is needed on patients more than 2 years old, as the literature to date is contradictory regarding the prognosis for these patients and the need for adjuvant therapy when the older child presents with stage I disease.",
author = "Connolly, {J. A.} and Gearhart, {John Phillip}",
year = "1993",
language = "English (US)",
volume = "20",
pages = "7--14",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Management of yolk sac tumors in children

AU - Connolly, J. A.

AU - Gearhart, John Phillip

PY - 1993

Y1 - 1993

N2 - The current trend toward minimizing treatment morbidity in children with yolk sac carcinomas is laudable. As most children will present with stage I disease and be cured by radical orchiectomy alone, careful surveillance is adequate with the knowledge that effective chemotherapy is available should tumor recur. All new yolk sac carcinomas in children should be reported to the Prepubertal Testicular Tumor Registry and should ideally be treated at institutions that have experience with surveillance protocols and pediatric oncology. In this way, prospective studies on treatment options can be initiated, and management controversies may ultimately be ironed out. In particular, more information is needed on patients more than 2 years old, as the literature to date is contradictory regarding the prognosis for these patients and the need for adjuvant therapy when the older child presents with stage I disease.

AB - The current trend toward minimizing treatment morbidity in children with yolk sac carcinomas is laudable. As most children will present with stage I disease and be cured by radical orchiectomy alone, careful surveillance is adequate with the knowledge that effective chemotherapy is available should tumor recur. All new yolk sac carcinomas in children should be reported to the Prepubertal Testicular Tumor Registry and should ideally be treated at institutions that have experience with surveillance protocols and pediatric oncology. In this way, prospective studies on treatment options can be initiated, and management controversies may ultimately be ironed out. In particular, more information is needed on patients more than 2 years old, as the literature to date is contradictory regarding the prognosis for these patients and the need for adjuvant therapy when the older child presents with stage I disease.

UR - http://www.scopus.com/inward/record.url?scp=0027398736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027398736&partnerID=8YFLogxK

M3 - Article

C2 - 8434438

AN - SCOPUS:0027398736

VL - 20

SP - 7

EP - 14

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 1

ER -